Global Soft Tissue Repair Market Size and Share Analysis 2023-2028
Soft tissue injury refers to damage to muscles, ligaments, or tendons throughout the body. It can occur during sports and exercise activities, as well as during simple daily tasks.
The current value of the soft tissue repair market is USD 13.5 billion and is projected to reach USD 17.9 billion by the end of the forecast period. The market is expected to grow at a compound annual growth rate (CAGR) of 4.93% during the study period.
USD 13.5 billion in 2021
Product, Application, Region
|No. of Companies Mentioned||
The COVID-19 pandemic initially had a significant impact on the market due to restrictions and reduced soft tissue repair procedures. A study conducted in Poland during the early phase of the pandemic showed a substantial decrease in dental procedures, including dental repair procedures. However, as the pandemic progressed, soft tissue repair procedures started to resume, leading to market growth. Changes implemented during the pandemic regarding orthopedic surgeries have also shown potential long-term benefits for medical orthopedic management. Therefore, although the pandemic initially had a negative impact, the market is expected to recover and grow during the forecast period.
Several factors are expected to drive market growth, including the increasing incidence of sports-related injuries, trauma cases, and the aging population. A study conducted in Canada revealed a high rate of injuries among collision sport participants in Canadian high schools, with varying prevalence rates for different body parts. Additionally, a significant percentage of the adult population in the United States has experienced traumatic events, leading to a higher number of injuries and subsequent soft tissue repair procedures. Furthermore, the market’s growth is expected to be enhanced by the development efforts of major market players. For example, Orthopaedic Implant Company introduced a low-profile wrist fracture plate designed to minimize soft tissue impingement. In conclusion, the growing incidence of sports-related injuries, rising trauma cases, and developments by major market players are expected to drive the growth of the soft tissue repair market. However, the high cost of surgical procedures may hinder market growth.
The market is segmented based on various factors, including product, application, and region.
Segmentation by Product
Tissue Fixation Devices – Suture Anchor, Sutures, Interference Screws, and Other Devices
Tissue Matrix – Synthetic Mesh and Biologic Mesh
Segmentation by Application
Pelvic and Vaginal Prolapse Repair
Segmentation by Region
North America – United States, Canada, and Mexico
Europe – United Kingdom, Germany, France, Spain, Italy, and Rest of Europe
Asia-Pacific – China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific
Latin America – Brazil, Argentina, and Rest of Latin America
Middle East and Africa – South Africa, GCC, and Rest of Middle East and Africa
In terms of product type, the tissue fixation devices segment dominated the market with a value of USD 7,344 million in 2022. It is projected to experience a compound annual growth rate (CAGR) of 4.63% during the forecast period.
Sutures are thread-like materials utilized in medical and surgical procedures to stitch or sew tissues together. They can be made from various materials, including silk, catgut, nylon, and polypropylene. The choice of suture depends on the specific surgical procedure and the type of tissue to be sutured. They can be absorbable, dissolving over time, or non-absorbable, remaining permanently in the body. Sutures play a vital role in promoting healing, minimizing scarring, reducing bleeding, and preventing infections. The growing prevalence of oral disorders and initiatives by key market players are expected to drive the growth of this segment over the forecast period.
Synthetic materials used in these products demonstrate superior performance due to their special features. For example, polydioxanone absorbable monofilament suture materials offer various sizes, excellent knot security, and minimal tissue reaction, as stated in the University of Guelph’s 2021 update. These synthetic sutures retain tensile strength longer than other absorbable materials and are commonly used. Market offerings generally provide advanced features and better results compared to natural sutures. Medtronic PLC, for instance, offers synthetic sutures made of absorbable synthetic polyester, polymer, glycomer, and a composition of other synthetic materials. These products provide enhanced initial strength, good knot security, quick absorption, and strong wound approximation during critical wound healing. As a result, the demand for synthetic suture materials is increasing, driving the growth of this segment. Synthetic sutures have gained global recognition and preference due to their clinical significance. In June 2022, the National Library of Medicine published an update on wound closure techniques, stating that synthetic sutures are preferred in most procedures due to limited reaction and minimal inflammation. The segment is expected to grow steadily based on the July 2022 article Absorbable Sutures: Chronicles and Applications, which highlights the high demand for synthetic sutures made from various absorbable polymers.
In terms of application, the orthopedics segment held the largest market share with a value of USD 3,949 million in 2022. It is anticipated to grow at a CAGR of 5.03% during the forecast period. This segment is set to experience significant growth primarily driven by the introduction of new products, an aging population, and the prevalence of soft tissue damage in joints. A study conducted during the Beijing Olympics 2022 revealed that 2,897 athletes from 91 countries experienced sports-related injuries or illnesses. The high prevalence of sports injuries supports the growth of this segment.
The increasing geriatric population worldwide is another crucial factor contributing to the demand for orthopedic soft tissue repair procedures. By 2030, it is estimated that 1 in 6 individuals globally will be aged 60 years or older, according to the World Health Organization’s data from October 2022. The share of the population aged 60 years and over is projected to increase from 1 billion in 2020 to 1.4 billion in 2030. Additionally, the number of people aged 80 and above will triple between 2020 and 2050, reaching 426 million.
As the demand for orthopedic products grows, major market players focus on product development and launches, further fueling market growth. For example, Panther Orthopedics, Inc. introduced its soft tissue platform technology, the PUMA System, for use in Lapidus surgeries. The PUMA System utilizes nitinol-based soft tissue fixation devices that stabilize soft tissue without over-compression or loosening through cyclical loading. Therefore, the rising prevalence of injuries, the growing geriatric population, and a higher number of product launches are expected to drive the growth of this segment over the forecast period.
Geographically, North America held the largest market share with a value of USD 5,362 million in 2022. It is projected to grow at a CAGR of 4.82% during the forecast period. The region’s dominance can be attributed to factors such as the increasing number of sports injuries, product innovations by major players, and the presence of advanced medical care facilities. In the United States, for instance, the soft tissue repair market benefits from advanced medical facilities, an aging population, a high incidence of sports injuries, and substantial healthcare expenditure. According to the National Safety Council of the United States, approximately 3.2 million people were treated in emergency departments in 2021 for injuries related to sports and recreational equipment. Exercise, cycling, and basketball were among the most common activities associated with injuries.
Furthermore, the increasing number of new product launches in North America contributes to market growth. OSSIO, Inc., for example, initiated the United States launch and commercial use of OSSEO fiber Suture Anchors in August 2022. These bio-integrative implants based on the OSSIOfiber Intelligent Bone Regeneration Technology offer exceptional strength and safety in foot/ankle, shoulder, knee, hand/wrist, and elbow surgeries.
In conclusion, the studied market exhibits substantial growth potential. Factors such as the dominance of tissue fixation devices in terms of product type, the preference for synthetic sutures, the significant share held by the orthopedics segment, the rising geriatric population, and the strong presence of North America in the market contribute to the anticipated growth over the forecast period.
The Soft Tissue Repair Market exhibits a moderate level of consolidation and is characterized by the presence of several prominent players. These market leaders currently hold a considerable share in the market due to factors such as substantial research funding and robust distribution systems, which have allowed them to establish strong positions. Notable players in this market include Arthrex, Inc., Baxter International, Inc., Boston Scientific Corporation, Medtronic, and Stryker, among others.
Key Companies Profiled in this report include Arthrex Inc., Baxter International Inc., Boston Scientific Corporation, Artivion, Inc. (CryoLife, Inc.), Integra LifeSciences Corporation, Johnson & Johnson, Medtronic plc, Becton, Dickinson and Company, Smith & Nephew plc, Stryker Corporation.
Recent Industry Developments
In December 2022, Stryker introduced the Citrefix suture anchor system, specifically designed for foot and ankle surgical procedures. This system utilizes a disposable anchor body made from a resorbable biomimetic material called Citregen. Citregen is an elastomeric substance derived from a citrate polymer, which mimics bone chemistry to enable controlled resorption without causing chronic inflammation. These unique chemical and mechanical properties of Citrefix are intended to promote healing of grafted tissue and facilitate healthy bone growth when employed in orthopedic surgical applications.
In May 2022, Paragon 28, Inc. launched the Grappler Suture Anchor System, specially developed to address the challenges associated with soft tissue tensioning and ligament reconstruction in acute procedures of the foot and ankle. Paragon 28 designed their acute Grappler anchors using PEEK and titanium materials to enhance efficiency in the operating room (OR). The PEEK anchors are available in 4.5 and 5.5 sizes and are conveniently preloaded with sutures and needles. They are offered as part of a single kit that includes all the necessary instrumentation to complete the repair process.
Key Questions Answered
What is the duration of the study period for this market?
What is the growth rate of the Soft Tissue Repair Market?
What was the size of the Soft Tissue Repair Market in 2018?
What is the projected size of the Soft Tissue Repair Market in 2028?
Which region exhibits the highest growth rate in the Soft Tissue Repair Market?
Which region holds the largest share in the Soft Tissue Repair Market?
Who are the major players in the Soft Tissue Repair Market?